The anabolic properties of GIP closely resemble those of insulin, as it promotes lipid uptake and inhibits lipolysis in adipocytes (59)
According to Endocrine Society and AACE guidelines, inadequate response (less than 5% weight loss after approximately 3 months at a maintenance dose) should prompt consideration of dose escalation or alternative therapies
Patients should understand that indirect effects of metabolic medications can influence cognitive function
Gordon I, Vander Wyk BC, Bennett RH, Cordeaux C, Lucas MV, Eilbott JA et al (2013)
on May 25, before the FDA announced the latest Ozempic and Wegovy shortage at the end of May, Novo Nordisk said that all doses of Ozempic were available to pharmacies for appropriate patients with type 2 diabetes, and that pharmacies may experience normal delays given the time required to order the product from their local distribution center, and geographical variabilities. While reporting this story, Novo Nordisk said, with respect to Wegovy, that prescribing trends continue to increase at a substantial rate and indicate that demand for Wegovy in the U.S
It's important to understand that this is a non-therapeutic dose